Should blood cultures be obtained in patients with cellulitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Blood Cultures in Cellulitis

Blood cultures should NOT be routinely obtained in typical, uncomplicated cellulitis cases 1.

When to Skip Blood Cultures (Most Cases)

For the majority of cellulitis patients presenting with localized skin infection without systemic signs, blood cultures are unnecessary and not cost-effective. The IDSA guidelines explicitly state with strong evidence that "cultures of blood or cutaneous aspirates, biopsies, or swabs are not routinely recommended" 1.

Why avoid routine blood cultures:

  • The yield is extremely low (4.8-10.8% positive rate) in uncomplicated cases 2, 3
  • False-positive contamination causes harm through unnecessary antibiotic escalation, prolonged hospitalization, and increased costs 4
  • In uncomplicated cellulitis, the chance of a false-positive culture exceeds the prevalence of true bacteremia 4

When Blood Cultures ARE Indicated

Blood cultures are strongly recommended when patients have: 1

High-Risk Patient Populations:

  • Malignancy on chemotherapy
  • Neutropenia
  • Severe cell-mediated immunodeficiency
  • Immersion injuries
  • Animal bites

Severe Systemic Features:

  • SIRS criteria (fever, tachycardia, tachypnea, abnormal WBC)
  • Hypotension or hemodynamic instability
  • Altered mental status
  • High fever with rigors/shaking chills 5

Specific Clinical Scenarios:

  • Age ≥65 years with systemic signs - bacteremia rate increases to 25.3% in elderly patients 5
  • Liver cirrhosis (OR 6.8 for bacteremia) 6, 2
  • Chronic kidney disease 2
  • Lymphedema 2
  • Ipsilateral orthopedic implant 2
  • WBC ≥13,000-13,500 cells/µL 5, 2
  • Cellulitis involving non-lower extremities (OR 4.0) 6
  • Alcoholism 3

Risk Stratification Algorithm

A validated scoring system can guide decision-making 6:

Calculate score:

  • 1 point: Age ≥65 years
  • 1.5 points: Non-lower extremity involvement
  • 2 points: Liver cirrhosis
  • 2.5 points: SIRS present

Risk categories:

  • Score ≤1.5 (Low risk): 1% bacteremia rate → Skip blood cultures
  • Score 2-3.5 (Medium risk): 14.7% bacteremia rate → Consider blood cultures
  • Score ≥4.0 (High risk): 41.2% bacteremia rate → Obtain blood cultures

Common Pitfalls to Avoid

  1. Don't obtain blood cultures reflexively in all hospitalized cellulitis patients - Studies show 52.5% of admitted patients get unnecessary blood cultures 3

  2. Don't delay antibiotics waiting for cultures - In appropriate cases requiring cultures, obtain them before starting antibiotics, but don't delay treatment 4

  3. Proper technique matters - If obtaining cultures, collect at least two sets of ≥7 mL from separate peripheral sites to distinguish true bacteremia from contamination 4

  4. Don't confuse purulent infections with cellulitis - Abscesses, septic bursitis, and purulent collections are NOT cellulitis and have different management algorithms 1

Clinical Context

When blood cultures are positive in cellulitis, the most common organisms are Streptococcus species (especially S. dysgalactiae at 62.5%) and Staphylococcus aureus 5, 3. MRSA is uncommon in typical cellulitis (only 3.6% required anti-MRSA therapy) 5, and β-lactams like cefazolin succeed in 96% of cases 1. This supports the guideline recommendation to treat typical cellulitis with streptococcal coverage alone, reserving broader coverage for specific high-risk scenarios.

The bottom line: Reserve blood cultures for elderly patients with systemic signs, immunocompromised hosts, or those with specific risk factors outlined above. For the otherwise healthy patient with localized cellulitis and no systemic toxicity, empiric antistreptococcal therapy without blood cultures is the evidence-based approach.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.